Last reviewed · How we verify
Cancer Stem Cells Sensitivity Assay
This drug targets cancer stem cells to inhibit tumor growth.
This drug targets cancer stem cells to inhibit tumor growth. Used for Cancer stem cells sensitivity assay.
At a glance
| Generic name | Cancer Stem Cells Sensitivity Assay |
|---|---|
| Also known as | Cancer stem cells in vitro chemo-sensitivity assay |
| Sponsor | Associazione Oncologia Traslazionale |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 2 |
Mechanism of action
The exact mechanism is not well understood, but it is believed to work by disrupting the self-renewal and differentiation of cancer stem cells, leading to a reduction in tumor growth and metastasis.
Approved indications
- Cancer stem cells sensitivity assay
Common side effects
- Unknown
Key clinical trials
- Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer (PHASE3)
- Feasibility Study on Stem Cells Sensitivity Assay (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |